Selank
Tuftsin analogue
Selank is a synthetic peptide related to tuftsin. The primary study discussed here examines neurotransmission-related gene expression in rats, not clinical outcomes in a general population.
Reviewed September 2026
- Residues
- 7. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 751.87 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 11.00 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
Calculated properties
| Formula | C33H57N11O9 |
|---|---|
| Monoisotopic mass | 751.4341 Da |
| Extinction coefficient at 280 nm | None (no Tyr or Trp) |
| A280 at 1 mg/mL | Not measurable |
| Residues | 7 |
| Average mass | 751.87 Da |
| pI | 11.00 (theoretical) |
| Aliases | Tuftsin analogue |
|---|---|
| Sequence | TKPRPGP |
| Research area | Neurological |
Property basis and sources
These describe the reference compound or formulation, not identification or testing of the supplied lot.
Calculation scope: the stored canonical amino-acid sequence with free N- and C-termini, no other modifications or counterions. This specifies a reference form, not the chemical form or identity of a sold lot.
- Residues: 7 (calculated). Count of residues in the stored canonical reference sequence; terminal groups are not extra residues. Residues source 1
- Average mass: 751.87 Da (calculated). Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded. Average mass source 1 Average mass source 2 Average mass source 3
- pI: 11.00 (theoretical) (calculated). Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation. pI source 1 pI source 2
Residue composition
- Unique residues
- 5
- Most common
- Proline
- Nonpolar residues
- 0
- Other classified residues
- 7
Proline is the most common residue (3). The calculated charge at pH 7 is net positive (1.99).
Reference scope and linked records
Reference type: Peptide.
This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.
Catalogue context: Selank. The product retains its own name and specification; this link does not certify equivalence to published study material.
Related references
Sources and their scope
- Selank administration and genes involved in GABAergic neurotransmission. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.
About Selank
Identity and context
The reported sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is different from Semax, despite both names appearing in neurological research catalogues. Comparisons should retain the complete identity rather than treating the two as alternative spellings or formulations.
Reference classification
Peptide. The linked catalogue product is Selank. This reference does not independently authenticate the material supplied.
Storage and handling
Analytical specification
Check the full sequence, terminal groups and analytical identity. Do not transfer stability, pharmacology or clinical claims from Semax to Selank simply because both are short peptides.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| What the source examines | Volkova and colleagues assessed gene expression in rat frontal cortex after Selank or GABA administration. They found time-dependent changes in a panel of neurotransmission-related genes and proposed involvement of the GABAergic system. Gene expression provides a mechanistic observation, not a direct measurement of anxiety relief in humans. | Source context |
| What cannot be inferred | This study does not establish that Selank acts exactly like a benzodiazepine, is free of adverse effects or has a proven benefit in the person reading this page. No regulatory status is inferred from the originating country of a paper. | Evidence limits |
References
Sources used for the data on this page, checked September 2026.
- Selank administration and genes involved in GABAergic neurotransmissionPrimary source for the reference discussion; not lot-specific product evidence.
Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.